Dengvaxia has been shown to be effective in reducing the incidence of dengue. In clinical trials, the vaccine demonstrated an overall efficacy of around 66% against symptomatic dengue disease. The benefits include a reduction in the number of severe dengue cases and a decrease in hospitalizations due to dengue.
